The trials were expected to commence earlier but were postponed after national regulators expressed the need to gather more information.
READ ALSO: BOKO HARAM: Bomb Blast Hits Gombe
A two-day meeting of the national regulatory authorities and ethics committees was hosted earlier this week by the World Health Organization (WHO) after which the UN agency stated that all aspects of the proposed trials had been thoroughly discussed.
“Reviewing countries requested additional documentation from the manufacturer of the vaccine, GlaxoSmithKline, before authorization of the trials,” the WHO said in a statement.
READ ALSO: PHOTOS: See Ghanaians Coffins Made For Alcohol Lovers [MUST SEE]
“If these steps are completed to the satisfaction of the national authorities, Phase II trials are likely to begin in February,” the statement added.
GSK’s vaccine is currently in the first phase of clinical trials and its suitability for use in humans is being tested in Switzerland, Britain, Mali and the United States.
Follow 4119ja on twitter
Click here to "like" the 4119ja Facebook page, to get updates directly on your Facebook timeline. Subscribe to our BBM Channel (C00379595D or search for "411 9ja") to get live updates on published post. Please drop your comments below
No comments:
Post a Comment